SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-14-001738
Filing Date
2014-03-26
Accepted
2014-03-26 07:15:57
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2013_soligenix.htm 10-K 1366477
2 SUBSIDIARIES OF THE COMPANY. f10k2013ex21i_soligenix.htm EX-21.1 11801
3 ACCOUNTANT'S CONSENT f10k2013ex23i_soligenix.htm EX-23.1 4294
4 CERTIFICATION f10k2013ex31i_soligenix.htm EX-31.1 15200
5 CERTIFICATION f10k2013ex31ii_soligenix.htm EX-31.2 15545
6 CERTIFICATION f10k2013ex32i_soligenix.htm EX-32.1 6097
7 CERTIFICATION f10k2013ex32ii_soligenix.htm EX-32.2 6242
  Complete submission text file 0001213900-14-001738.txt   7191749

Data Files

Seq Description Document Type Size
8 XBRL sngx-20131231.xml EX-101.INS 1024855
9 XBRL sngx-20131231.xsd EX-101.SCH 49633
10 XBRL sngx-20131231_cal.xml EX-101.CAL 40175
11 XBRL sngx-20131231_def.xml EX-101.DEF 190728
12 XBRL sngx-20131231_lab.xml EX-101.LAB 447715
13 XBRL sngx-20131231_pre.xml EX-101.PRE 330719
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16929 | Film No.: 14717344
SIC: 2834 Pharmaceutical Preparations